Intervention not reported
Quality of life · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
PEI versus surgery · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival (OS) · HER2‐positive early breast cancer patients
The intervention leads to lower overall survival (OS) (high certainty).
1 finding from 1 review
Intervention not reported
Disease free survival (DFS) · HER2‐positive early breast cancer patients
The intervention leads to lower disease free survival (DFS) (high certainty).
1 finding from 1 review
Intervention not reported
Congestive heart failure (CHF) · HER2‐positive early breast cancer patients
The intervention leads to higher congestive heart failure (CHF) (high certainty).
1 finding from 1 review
Intervention not reported
Left ventricular ejection fraction decline (LVEF) · HER2‐positive early breast cancer patients
The intervention probably leads to higher left ventricular ejection fraction decline (LVEF) (moderate certainty).
1 finding from 1 review
Intervention not reported
Brain metastasis as first site of relapse · HER2‐positive early breast cancer patients
The intervention may leads to higher brain metastasis as first site of relapse (low certainty).
1 finding from 1 review
Intervention not reported
Death within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in death within 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Disease progression within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention probably leads to lower disease progression within 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Haematological adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in haematological adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Gastrointestinal adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in gastrointestinal adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Genitourinary adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in genitourinary adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Groin recurrence · patients with Early Vulvar Cancer
Primary Groin Radiotherapy showed no clear difference in groin recurrence compared with primary Groin Surgery (low certainty).
1 finding from 1 review
Disease specific mortality · patients with Early Vulvar Cancer
Primary Groin Radiotherapy showed no clear difference in disease specific mortality compared with primary Groin Surgery (low certainty).
1 finding from 1 review
Pain with dilation (10 mL 2% lidocaine)a,b · people requesting a surgical abortion at 13+6 weeks' gestation or less (Chin 2020 included people experiencing an early pregnancy loss)
1 finding from 1 review
Pain with dilation (20 mL 1% lidocaine)d,e · people requesting a surgical abortion at 13+6 weeks' gestation or less (Chin 2020 included people experiencing an early pregnancy loss)
1 finding from 1 review
Pain with aspiration (lidocaine)a,b · people requesting a surgical abortion at 13+6 weeks' gestation or less (Chin 2020 included people experiencing an early pregnancy loss)
1 finding from 1 review
Pain with aspiration (20 mL 1% lidocaine)d,e · people requesting a surgical abortion at 13+6 weeks' gestation or less (Chin 2020 included people experiencing an early pregnancy loss)
1 finding from 1 review
Effect on later sexual function · symptomatic or early postmenopausal women1.
4 findings from 1 review
no estimate extracted
3 studies · 699 participants
Moderate
no estimate extracted
1 study · 883 participants
Very low
no estimate extracted
1 study · 215 participants
Very low
Show 1 more finding
Estrogen + progestogens · symptomatic or early postmenopausal women1.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found